Place:
Online
Date:
7-9 October 2021
09:15
14th International Cardiovascular Reasearch Meeting
Conference under the auspices of the Bydgoszcz Chapter of the Polish Cardiac Society
SCIENTIFIC PROGRAMME
We invite you to familiarize yourself with the details of the program.
09:15 - 09:20
Opening speech
Jacek Kubica
09:20 - 09:40
Coronary revascularization plus medical therapy or medical therapy alone in elective patients with chronic coronary syndrome (Lecture of the day)
Eliano P. Navarese
09:40 - 09:45
Break
09:45 - 11:00
SESSION 1
09:45 - 10:00
Reduced hospital admissions and increased mortality for acute Heart Failure during COVID-19 pandemic in Poland: a multicentre study (HF-COV-SIRIO 6 study)
Małgorzata Ostrowska
10:00 - 10:15
Predictors of in-hospital clinical outcome in COVID-19 patients
Klaudyna Grzelakowska
10:15 - 10:30
Determinants of anti-SARS-CoV-2 antibodies after vaccination
Magdalena Krintus
10:30 - 10:45
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the COVID-19 (The IMPACT COVID 19 - SIRIO 5 randomized study)
Jacek Kubica
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 2
11:15 - 11:30
Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines
Marco Cattaneo
11:30 - 11:45
Optimal Antithrombotic treatment in COVID-19 Patients
Giuseppe Patti
11:45 - 12:00
Biomarkers of Thrombosis in COVID-19
Diana Gorog
12:00 - 12:15
Aspirin as an Ideal Pharmacologic Therapy for COVID-19
Udaya Tantry
12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 3
12:45 - 13:00
Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition
Paul A. Gurbel
13:00 - 13:15
Ethnic difference of thrombogenicity in patients with coronary artery disease
Young-Hoon Jeong
13:15 - 13:30
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention
Jolanta Siller-Matula
13:30 - 13:45
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Andrzej Budaj
13:45 - 14:00
Mortality risk prediction in patients with cardiogenic shock (The CardShock study)
Salvatore di Somma
14:00 - 14:15
DISCUSSION
14:15 - 16:15
SESSION 4 - ELECTRA trial investigators meeting
09:00 - 09:20
PCSK9 vaccine – a future therapeutic option or illusory hopes (Lecture of the day)
Maciej Banach
09:20 - 09:30
Break
09:30 - 11:00
SESSION 6
09:30 - 09:45
Acute coronary syndromes in elderly patients
Stefano De Servi
09:45 - 10:00
Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction (The COOL AMI EU Pivotal Trial)
Marko Noc
10:00 - 10:15
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention (The TWILIGHT Trial)
Robert Gil
10:15 - 10:30
Resorbable Magnesium Scaffold in ACS patients
Magdalena Łanocha
10:30 - 10:45
Baseline electrocardiographic predictors of Left Ventricular Remodeling in STEMI
Tomasz Fabiszak
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 7
11:15 - 11:30
Rivaroxaban in Peripheral Artery Disease (The VOYAGER PAD Trial)
Marc Bonaca
11:30 - 11:45
Venous Thromboembolism in cancer patients
Adam Torbicki
wykład sponsorowany przez firme Pfizer
11:45 - 12:00
Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy
Klemen Steblovnik
12:00 - 12:15
Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model
Leszek Gromadziński
12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 8
12:45 - 13:00
NCU-AF: on-line qualification for ablation of atrial fibrillation and left atrial appendage occlusion
Piotr Adamski
13:00 - 13:15
Management of patients with coronary artery disease in Lithuania
Jolita Badariene
13:15 - 13:30
Outcomes of managed care in acute myocardial infarction survivors survivors
Piotr Jankowski
13:30 - 13:45
Determinants of elevated lipid parameters in patients without diagnosed car-diovascular disease - results from the polish arm of the EUROASPIRE V sur-vey
Jakub Ratajczak
13:45 - 14:00
PCSK9 inhibitors in acute coronary syndrome
Miłosz Jaguszewski
14:00 - 14:15
DISCUSSION
14:15 - 14:30
Break
14:30 - 15:45
SESSION 9
14:30 - 14:45
Impact of COVID-19 on clinical outcome in acute coronary syndrome patients
Wojciech Wojakowski
14:45 - 15:00
Renal injury in patients admitted due to Covid-19 – single centre experience
Małgorzata Jasiewicz
15:00 - 15:15
Electrotherapy in the COVID-19 era in Poland
Jarosław Kaźmierczak
15:15 - 15:30
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Marek Postuła
15:30 - 15:45
DISCUSSION
15:45 - 17:00
SIRIO MEDICINE network meeting
09:00 - 09:20
On the Shades of Coronary Calcium and Plaque Instability - (Lecture of the day)
Eloisa Arbustini
09:20 - 09:30
Break
09:30 - 11:00
SESSION 11
09:30 - 09:45
Levosimendan improves the acute course of takotsubo syndrome
Miłosz Jaguszewski
09:45 - 10:00
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Fail-ure and Reduced Ejection Fraction
Jarosław Drożdż
10:00 - 10:15
Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock (CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry)
Przemysław Trzeciak
10:15 - 10:30
Long-term outcomes following drug-eluting balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis (DEB-Dragon-Registry)
Piotr Niezgoda
10:30 - 10:45
The impact of the COVID-19 pandemic on the functioning of the emergency medical service
Michał Kasprzak
10:45 - 11:00
DISCUSSION
11:00 - 11:15
Closing remarks
Jacek Kubica
